Literature DB >> 15017003

De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine.

Anna-Pavlina G Haramis1, Harry Begthel, Maaike van den Born, Johan van Es, Suzanne Jonkheer, G Johan A Offerhaus, Hans Clevers.   

Abstract

Little is known about the signaling mechanisms that determine the highly regular patterning of the intestinal epithelium into crypts and villi. With the use of mouse models, we show that bone morphogenetic protein (BMP)-4 expression occurs exclusively in the intravillus mesenchyme. Villus epithelial cells respond to the BMP signal. Inhibition of BMP signaling by transgenic expression of noggin results in the formation of numerous ectopic crypt units perpendicular to the crypt-villus axis. These changes phenocopy the intestinal histopathology of patients with the cancer predisposition syndrome juvenile polyposis (JP), including the frequent occurrence of intraepithelial neoplasia. Many JP cases are known to harbor mutations in BMP pathway genes. These data indicate that intestinal BMP signaling represses de novo crypt formation and polyp growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017003     DOI: 10.1126/science.1093587

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  243 in total

1.  Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion.

Authors:  Anisa Shaker; Elzbieta A Swietlicki; Lihua Wang; Shujun Jiang; Birce Onal; Shashi Bala; Katherine DeSchryver; Rodney Newberry; Marc S Levin; Deborah C Rubin
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5⁺ stem cell.

Authors:  Shiro Yui; Tetsuya Nakamura; Toshiro Sato; Yasuhiro Nemoto; Tomohiro Mizutani; Xiu Zheng; Shizuko Ichinose; Takashi Nagaishi; Ryuichi Okamoto; Kiichiro Tsuchiya; Hans Clevers; Mamoru Watanabe
Journal:  Nat Med       Date:  2012-03-11       Impact factor: 53.440

3.  Functional Cftr in crypt epithelium of organotypic enteroid cultures from murine small intestine.

Authors:  Jinghua Liu; Nancy M Walker; Matthew T Cook; Akifumi Ootani; Lane L Clarke
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-07       Impact factor: 4.249

Review 4.  Molecular mediators of mesenchymal stem cell biology.

Authors:  Maria P Alfaro; Sarika Saraswati; Pampee P Young
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

5.  The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers.

Authors:  Javier Muñoz; Daniel E Stange; Arnout G Schepers; Marc van de Wetering; Bon-Kyoung Koo; Shalev Itzkovitz; Richard Volckmann; Kevin S Kung; Jan Koster; Sorina Radulescu; Kevin Myant; Rogier Versteeg; Owen J Sansom; Johan H van Es; Nick Barker; Alexander van Oudenaarden; Shabaz Mohammed; Albert J R Heck; Hans Clevers
Journal:  EMBO J       Date:  2012-06-12       Impact factor: 11.598

Review 6.  Regulation of gene expression in the intestinal epithelium.

Authors:  Camilla A Richmond; David T Breault
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 7.  The intestinal stem cell.

Authors:  Luis A Chia; Calvin J Kuo
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 8.  Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.

Authors:  Douglas B Stairs; Jianping Kong; John P Lynch
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 9.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

Review 10.  Biology of BMP signalling and cancer.

Authors:  M Blanco Calvo; V Bolós Fernández; V Medina Villaamil; G Aparicio Gallego; S Díaz Prado; E Grande Pulido
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.